# BD Viper LT System

> Active: European Union and United States. Medical device record on deviCERTS, compiled from public registries.

- Canonical page: <https://devicerts.com/devices/bd-viper-lt-system-ooi>
- Manufacturer: [Becton, Dickinson and Company](https://devicerts.com/manufacturers/becton-dickinson-and-company) (United States)
- Name in the registry: BD VIPER LT SYSTEM
- Device class: Class II (US FDA)
- FDA product code: OOI

## Overview

*AI-generated summary, 2026-09-18. Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data is the record.*

The BD Viper LT System is a Real-Time Nucleic Acid Amplification System designed for automated molecular diagnostics. It performs nucleic acid extraction, amplification, and detection to enable high-throughput testing in clinical chemistry applications, including HPV genotyping.

This bench-top system is intended for use in laboratory settings with automated workflows, reducing hands-on time. Supplied as a reusable device, it requires FDA 510K clearance and IVDR compliance. The system operates under non-sterile conditions and is not MRI-safe. Specific assay kits, such as the BD Onclarity HPV Assay, are used in conjunction with the system for testing.

## Registrations and authorizations

- **510(k)** · FDA 510(k) · United States · K140447 · decision 2014-05-20 · decision SESE · status: Active
- **EUDAMED** · CE/IVDR · European Union · status: Active

## Recalls

- Z-1866-2017 · Class II · terminated · initiated 2015-12-14: BD has confirmed reports that lower than expected RFU values were generated on customer BD Viper LT Systems after the installation of software version 3.00H. As RFU values decrease, results approach the assay cutoff threshold which has the potential to impact test results.
- Z-1816-2015 · Class II · terminated · initiated 2014-11-07: Potential for false positive Chlamydia trachomatis (CT) results and Neisseria gonorrhoeae (GC) results when processing the CT Qx and GC Qx Assays on the BD Viper LT Instrument.

## Identifiers

- 510(k) Number: K140447 [FDA 510(k)]
- FDA product code: OOI [FDA 510(k)]

## Classification

- Device class: Class II [FDA 510(k)]
- Regulation: 21 CFR Part 862.2570 [FDA 510(k)]
- Advisory committee: Clinical Chemistry [FDA 510(k)]
- FDA decision: SESE [FDA 510(k)]

## Source and citation

- Cite as: BD Viper LT System, Becton, Dickinson and Company. deviCERTS medical device catalogue. https://devicerts.com/devices/bd-viper-lt-system-ooi (data as of 2026-11-21).
- Data sources: [FDA 510(k)](https://open.fda.gov/apis/device/510k/), [EUDAMED](https://ec.europa.eu/tools/eudamed), [FDA recalls](https://open.fda.gov/apis/device/recall/)
- Registry records last synced: 2026-10-22
- Statuses computed as of: 2026-11-21
- JSON: <https://devicerts.com/devices/bd-viper-lt-system-ooi.json>
- Licence: [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/). The deviCERTS layout and text are licensed under CC BY 4.0. Registry data remain under their source terms: U.S. FDA data (openFDA, AccessGUDID) are U.S. public domain; EUDAMED data are subject to the European Commission reuse terms.
- Attribution: DevicErts, https://devicerts.com/devices/bd-viper-lt-system-ooi
- Compiled by deviCERTS (devicerts.com) from public medical device registries (EUDAMED, European Commission; U.S. FDA via openFDA; AccessGUDID, U.S. National Library of Medicine). deviCERTS is not an official register and gives no regulatory advice: the record in the registry itself prevails.
